Position in NBIX
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$29,648,218
+$11,326,903 QoQ
Shares Held
225,051
+74.2% QoQ
Ownership
0.224%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 95.50946229965652.ToString("F0")%
Shared 0.ToString("F0")%
None 4.490537700343477.ToString("F0")%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026PRUDENTIAL FINANCIAL INC holds $156,211,352 across 33 Drug Manufacturers - Specialty & Generic names. NBIX ranks #1 (19.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
This page
|
225,051 | $29,648,218 | |
| 2 | ZTS |
Zoetis Inc.
|
202,071 | $23,886,812 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
34,281 | $20,327,947 | |
| 4 | ELAN |
Elanco Animal Health Inc
|
449,847 | $10,764,838 | |
| 5 | INDV |
Indivior Pharmaceuticals, Inc.
|
286,100 | $8,720,328 | |
| 6 | VTRS |
Viatris Inc
|
597,766 | $8,075,817 | |
| 7 | AMRX |
Amneal Pharmaceuticals, Inc.
|
511,957 | $6,363,625 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
|
207,156 | $6,239,538 |
All Filings in NBIX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $29,648,218 | 225,051 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $18,321,315 | 129,178 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $14,437,802 | 102,848 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $18,266,527 | 145,330 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $13,194,580 | 119,300 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $28,688,887 | 210,175 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $20,362,254 | 176,725 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $26,742,947 | 194,254 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $16,014,993 | 116,118 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $43,397,922 | 329,371 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $31,406,287 | 279,167 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $8,114,514 | 86,050 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $6,485,164 | 64,070 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $6,554,507 | 54,877 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $5,273,324 | 49,650 | Shares | Defined | 2022-11-04 | |
| 2022-06-30 | $2,891,157 | 29,659 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $5,704,779 | 60,851 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $1,864,286 | 21,889 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,706,526 | 17,793 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $2,269,793 | 23,323 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $3,747,139 | 38,531 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $6,378,528 | 66,547 | Shares | Defined | 2021-08-16 | |
| 2020-09-30 | $227,033 | 2,361 | Shares | Defined | 2021-08-05 | |
| 2020-06-30 | $254,614 | 2,087 | Shares | Defined | 2021-08-05 | |
| 2020-03-31 | $163,925 | 1,894 | Shares | Defined | 2021-08-05 | |
| No filing history on record for this holder in this stock. | ||||||